Decreased neutrophil-to-lymphocyte ratio predicted cognitive improvement in late-life depression treated with vortioxetine: Findings from an eight-week randomized controlled trial

Lingfeng Xue, Elin Lewis, Mariia Bocharova, Allan H. Young, Dag Aarsland

Open source

DOI
10.1016/j.bbi.2025.01.029
Published
2025-05
Container
Brain, Behavior, and Immunity
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.bbi.2025.01.029,
  title = {Decreased neutrophil-to-lymphocyte ratio predicted cognitive improvement in late-life depression treated with vortioxetine: Findings from an eight-week randomized controlled trial},
  author = {Lingfeng Xue and Elin Lewis and Mariia Bocharova and Allan H. Young and Dag Aarsland},
  year = {2025},
  journal = {Brain, Behavior, and Immunity},
  doi = {10.1016/j.bbi.2025.01.029},
  url = {https://doi.org/10.1016/j.bbi.2025.01.029}
}

RIS

TY  - JOUR
TI  - Decreased neutrophil-to-lymphocyte ratio predicted cognitive improvement in late-life depression treated with vortioxetine: Findings from an eight-week randomized controlled trial
AU  - Lingfeng Xue
AU  - Elin Lewis
AU  - Mariia Bocharova
AU  - Allan H. Young
AU  - Dag Aarsland
PY  - 2025
JO  - Brain, Behavior, and Immunity
DO  - 10.1016/j.bbi.2025.01.029
UR  - https://doi.org/10.1016/j.bbi.2025.01.029
ER  - 

APA

Xue, L., Lewis, E., Bocharova, M., Young, A. H., & Aarsland, D. (2025). Decreased neutrophil-to-lymphocyte ratio predicted cognitive improvement in late-life depression treated with vortioxetine: Findings from an eight-week randomized controlled trial. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2025.01.029

Source records